By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full ...

Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and ...

Regeneron Pharmaceuticals said on Monday its experimental weight-loss drug combination helped preserve muscle mass in a ...

A global review reveals over 100 new dementia drugs which could halt or even reverse the disease are going through clinical ...

Regeneron Pharmaceuticals, Inc. (REGN) on Monday said that it has entered into a strategic in-licensing agreement with ...

A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...

Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs ...